A Multi-centre, Multinational, Prospective Observational Registry to Collect Safety and Outcome Data in Patients Diagnosed With Severe Hepatic VOD Following Hematopoietic Stem Cell Transplantation (HSCT) and Treated With Defitelio® or Supportive Care (Control Group)

Trial Profile

A Multi-centre, Multinational, Prospective Observational Registry to Collect Safety and Outcome Data in Patients Diagnosed With Severe Hepatic VOD Following Hematopoietic Stem Cell Transplantation (HSCT) and Treated With Defitelio® or Supportive Care (Control Group)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Jul 2018

At a glance

  • Drugs Defibrotide (Primary)
  • Indications Veno-occlusive disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jul 2018 Planned End Date changed from 1 Dec 2018 to 17 Jul 2019.
    • 23 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 17 Jul 2019.
    • 23 Jul 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top